TNXP
Tonix Pharmaceuticals Holding Corp
Price:  
0.38 
USD
Volume:  
1,598,200.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TNXP Fair Value

-2,079.89 %
Upside

As of 2024-03-01, the Fair Value of Tonix Pharmaceuticals Holding Corp (TNXP) is -7.49 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.38 USD, the upside of Tonix Pharmaceuticals Holding Corp is -2,079.89%.

Note: valuation result may not be accurate due to the company's negative EPS.

0.38 USD
Stock Price
-7.49 USD
Fair Price
FAIR VALUE CALCULATION

TNXP Fair Value

Peter Lynch's formula is:

TNXP Fair Value
= Earnings Growth Rate x TTM EPS
TNXP Fair Value
= 5.00 x -1.50
TNXP Fair Value
= -7.49

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31 5Y Avg
Net income -26.09 -28.62 -50.46 -92.29 -110.22 -61.54
YoY growth -23.53% -9.70% -76.31% -82.90% -19.43% -42.37%

TNXP Fair Value - Key Data

Market Cap (mil) 30.56
P/E
Forward P/E
EPS -1.50
Avg earnings growth rate -42.37%
TTM earnings -121.03